Tesamorelin
Tesamorelin Acetate
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Tesamorelin Overview
Tesamorelin is a synthetic analog of GHRH, designed to modulate somatotroph axis signaling. In preclinical and experimental research, it has been studied for its ability to influence endocrine pathway activity, regulate downstream cascades, and support investigations into systemic signaling dynamics.
History
Tesamorelin is a synthetic analog of GHRH, designed to modulate somatotroph axis signaling. In preclinical and experimental research, it has been studied for its ability to influence endocrine pathway activity, regulate downstream cascades, and support investigations into systemic signaling dynamics.
Tesamorelin Structure
CAS #: 901758-09-6
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: ~5135.9 g/mol
PubChem ID: 16132314
Research Findings
Tesamorelin has been studied in endocrine, signaling, and molecular models, with research highlighting its activity in somatotroph axis modulation, downstream cascades, pathway dynamics, and protein synthesis pathways. Studies also report effects on lipid pathway signaling, endocrine markers, and molecular proliferation in preclinical systems.
Key Areas of Research:
-
Endocrine: Somatotroph axis, signaling, cascades
-
Signaling: Lipid pathways, dynamics, markers
-
Molecular: Proliferation, remodeling, protein synthesis
Together, these findings suggest broad experimental potential for Tesamorelin across endocrine, signaling, and molecular pathways. By modulating somatotroph axis activity and influencing downstream cascades and protein synthesis processes, Tesamorelin provides a versatile research platform for exploring molecular remodeling, pathway characterization, and endocrine biology in laboratory settings.